O. Krieger

Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS)

Ulrich Germing, Barbara Hildebrandt, Michael Pfeilstöcker et al. · Leukemia · 2005 · 161 citations

Medicine, Clinical Sciences, Risk Assessment +10

Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM)

Matteo Giovanni Della Porta, Heinz Tuechler, Luca Malcovati et al. · Leukemia · 2015 · 136 citations · Full text

Medicine, Clinical Sciences, Hematology +15

Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): A multicenter study

Ulrich Germing, Michael Lauseker, Barbara Hildebrandt et al. · Leukemia · 2012 · 124 citations

Medicine, Hematology, Oncology +11

Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q

Mar Mallo, José Cervera, Julie Schanz et al. · Leukemia · 2010 · 120 citations · Full text

Life Sciences, Genetics, Hematology +17

Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study Group

Wolfgang R. Sperr, Friedrich Wimazal, Michael Kundi et al. · Annals of Oncology · 2009 · 116 citations · Full text

Education, Clinical Sciences, Clinical Classification Systems +14